Visalytics
Visalytics
approved EB-2 (NIW)

Research Specialist

Biostatistics · China · 2024-01-31

Processing Time
5 days
Decision Date
2024-01-31
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue improving advanced biostatistical techniques for cardiovascular disease clinical trials. This work focuses on supporting better treatment protocols, patient outcomes, and healthcare policies through the creation of robust clinical trial methodologies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research in biostatistics for cardiovascular clinical trials was found to have broad implications for the U.S. healthcare system and medical research.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 22 publications, 132 citations, and funding from major pharmaceutical companies demonstrated they are well-positioned.

3 Balance of Factors Met

USCIS concluded that the petitioner's success in developing advanced protocols and policies using biostatistical techniques justified a waiver of the job offer requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's M.S. in applied economics and a strong record of 22 peer-reviewed journal articles in 7 highly ranked journals. The work accumulated 132 citations and received significant funding from major pharmaceutical entities including Cytokinetics, AstraZeneca, and Novartis, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Original Contributions

Similar Cases

Statistician

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
New Jersey 50 days 2025-03-09
The petitioner proposes to enhance the design and analysis of clinical trials through advanced statistical methodologies and machine learning. His work focuses on creating innovative tools that optimize clinical trial accuracy and accelerate therapeutic approvals for oncology, cardiovascular diseases, and infectious diseases. This endeavor aims to improve public health outcomes by ensuring regulatory compliance and addressing safety evaluation challenges in complex medical conditions.
View Case

Research Scientist

Research and Development · China

WeGreened EB-2 (NIW) approved
New Jersey 367 days 2022-04-05
The petitioner proposes to develop and apply novel statistical methodologies to more accurately evaluate healthcare data and improve treatment efficacy. Her work focuses on characterizing the mechanisms for conditions such as cancer and COVID-19 to improve global treatment strategies.
View Case

Research Scientist

Research and Development · China

WeGreened EB-2 (NIW) approved
Massachusetts 151 days 2025-02-27
The petitioner proposes to refine statistical methodologies for experimental and observational studies to improve the quality of clinical data interpretation. Her work focuses on enhancing the reliability of healthcare research across various disease contexts, specifically ensuring that real-world evidence from large-scale datasets is evaluated with scientific rigor.
View Case

Researcher

Biotechnology · Brazil

WeGreened EB-2 (NIW) approved
126 days 2022-03-29
The petitioner proposes to continue her research on cardiovascular disease to facilitate the development of novel treatments and improve existing therapeutic approaches. Her work specifically focuses on elucidating the pathophysiology of cardiovascular diseases to advance next-generation medical interventions.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-01-31.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 5 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist